JAK1 and neoplasm: To determine the functional consequence of targeting the rewired LKB1-cIAP1-JAK1 trimolecular complex in an in vivo setting, we examined the anti-tumor activity of IAP inhibitors using our developed LKB1-mut mouse model36,59.